intermittent neutrophil recovery associated with improved car-t outcomes in r/r lbcl
Published 1 year ago • 110 plays • Length 4:39Download video MP4
Download video MP3
Similar videos
-
0:41
neutrophil recovery phenotypes observed in patients following cd19 car t-cell therapy
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
4:12
opportunities to improve car-t outcomes
-
2:53
understanding how patients relapse from car t-cell therapy
-
2:54
the 8 steps of car t-cell therapy
-
3:18
rosie's story: treating retinitis pigmentosa
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
4:49
hematopoietic recovery post-car-t
-
2:17
the role of car t-cell therapy for treating myeloma in the era of bispecific antibodies
-
3:03
the impact of salvage and bridging therapy on car t-cell therapy outcomes in b-all: an itt analysis
-
2:20
the risk of t-cell malignancies associated with car t-cell therapy
-
1:15
car t-cells in hematological malignancies
-
1:09
the promise of car t-cell therapy in hematological malignancies
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
3:21
patient-reported outcomes with car t-cell therapy
-
1:07
optimizing car-t therapy: regulating car t-cells in vivo
-
3:05
car-t therapy in r/r dlbcl
-
2:11
improving treatment outcomes of car t-cell therapy
-
1:56
car t-cell therapy for relapsed all with cns involvement
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics